https://www.selleckchem.com/products/ink128.html
30, 0.64), 12 months (RR = 0.46, 95%CI 0.30, 0.69), and over 24 months (RR = 0.58, 95% CI 0.35, 0.95) after treatment, compared with those receiving NBI. CBTp was also associated with more reduced attenuated psychotic symptoms by 12 months (SMD = -0.17, 95% CI -0.33, -0.02) and by 24 months (SMD = -0.24, 95% CI -0.43, -0.06). No beneficial effects on functioning, depression, quality of life, or distress were observed favoring CBTp. CBTp is effective in reducing both psychosis transition rates and attenuated psychotic symptoms for the pro
Like
Comment
Share
